![The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines | Nature Nanotechnology The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines | Nature Nanotechnology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41565-021-01001-3/MediaObjects/41565_2021_1001_Fig1_HTML.png)
The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines | Nature Nanotechnology
![Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses | PNAS Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses | PNAS](https://www.pnas.org/cms/asset/2de643c2-7c12-4647-9f85-d316cb6f075b/keyimage.jpg)
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses | PNAS
![Vaccines | Free Full-Text | Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations Vaccines | Free Full-Text | Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations](https://www.mdpi.com/vaccines/vaccines-09-00221/article_deploy/html/images/vaccines-09-00221-g001.png)
Vaccines | Free Full-Text | Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations
![Self-amplifying mRNA bicistronic influenza vaccines raise cross-reactive immune responses in mice and prevent infection in ferrets: Molecular Therapy - Methods & Clinical Development Self-amplifying mRNA bicistronic influenza vaccines raise cross-reactive immune responses in mice and prevent infection in ferrets: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/6062b00f-e6e9-4767-addd-318572cb4644/fx1_lrg.jpg)
Self-amplifying mRNA bicistronic influenza vaccines raise cross-reactive immune responses in mice and prevent infection in ferrets: Molecular Therapy - Methods & Clinical Development
![Suspicions grow that nanoparticles in Pfizer's COVID-19 vaccine trigger rare allergic reactions | Science | AAAS Suspicions grow that nanoparticles in Pfizer's COVID-19 vaccine trigger rare allergic reactions | Science | AAAS](https://www.science.org/do/10.1126/science.abg2359/abs/vaccine_1280p_3.jpg)
Suspicions grow that nanoparticles in Pfizer's COVID-19 vaccine trigger rare allergic reactions | Science | AAAS
![COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee - ScienceDirect COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1939455121000119-gr1.jpg)
COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee - ScienceDirect
![Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives - Sampath - 2021 - Allergy - Wiley Online Library Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives - Sampath - 2021 - Allergy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/38fc4943-2b97-45eb-b0d8-2c74bf1d7ff2/all14840-fig-0002-m.jpg)
Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives - Sampath - 2021 - Allergy - Wiley Online Library
![Frontiers | R848 Adjuvant Laden With Self-Assembled Nanoparticle-Based mRNA Vaccine Elicits Protective Immunity Against H5N1 in Mice Frontiers | R848 Adjuvant Laden With Self-Assembled Nanoparticle-Based mRNA Vaccine Elicits Protective Immunity Against H5N1 in Mice](https://www.frontiersin.org/files/Articles/836274/fimmu-13-836274-HTML-r1/image_m/fimmu-13-836274-g001.jpg)
Frontiers | R848 Adjuvant Laden With Self-Assembled Nanoparticle-Based mRNA Vaccine Elicits Protective Immunity Against H5N1 in Mice
![Frontiers | Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response Frontiers | Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response](https://www.frontiersin.org/files/Articles/878943/fimmu-13-878943-HTML-r1/image_m/fimmu-13-878943-g004.jpg)
Frontiers | Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response
![From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases - ScienceDirect From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1742706121003974-ga1.jpg)